Connect with us

DR Congo introduces new drug to fight sleeping sickness


DR Congo introduces new drug to fight sleeping sickness

The authorities in the Democratic Republic of Congo have started distributing a new oral drug to fight against sleeping sickness.

The disease, caused by a parasite that attacks the nervous system, is fatal if it is not treated. It affects at least eight million people in about 30 different African countries.

Congolese health officials together with pharmaceutical companies and non-governmental organisations (NGOs) have been working on the drug – called Fexidazole – for 10 years.

MORE READING!  COVID-19: Ugandan Pastor who called pandemic 'a common flu' arrested for uttering false information and harmful propaganda

It is a 10-day oral treatment taken daily which the patient can administer themselves.

The authorities have started distributing it across the country.

Sleeping sickness, or human African trypanosomiasis, is transmitted by the bite of an infected tsetse fly.

The early stages of the illness is similar to malaria – with fever, muscle pain and headache. This is when the parasite is outside the central nervous system.

MORE READING!  COVID-19: Kano NMA distributes face mask, sanitizers worth N5m to members

But once the parasite enters the nervous system at stage two, it can lead to death if left untreated.

Effective medicine to treat the disease had been elusive – some of the drugs used were toxic and complicated to administer.

The new drug will be a relief for victims who live in rural areas and have limited access to health care.

MORE READING!  COVID-19: Masquerader arrested for defying order in Ogun

Sleeping sickness affects 36 sub-Saharan African countries, including the DR Congo.

Click to comment

More in General

Most Read

Just In

To Top